首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1467656

2024-2032 年重组蛋白市场报告（按产品、应用、最终用户和地区）

Recombinant Protein Market Report by Product, Application, End User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

IMARC Group年全球重组蛋白市场规模达19.0亿美元。

重组蛋白是指由重组DNA编码的修饰或改变的蛋白。重组DNA分子由质粒组成，其中克隆了目标蛋白的基因。它是透过分子克隆或聚合酶链反应（PCR）产生的。一些常见的产品变体包括激酶蛋白、人类胰岛素、结构蛋白、黏附分子和受体、免疫反应蛋白等。它被许多生物製药公司、学术和研究机构、合约研究组织等广泛采用。

重组蛋白市场趋势：

几种慢性疾病盛行率的上升以及对新型治疗方案的需求不断增加，主要推动了全球重组蛋白市场的发展。除此之外，蛋白质工程领域的投资不断增加以及对蛋白质药物开发的日益关注正在进一步促进市场成长。此外，许多政府机构正在资助研发活动，以引进蛋白质体学和基因组学的先进技术，这对全球重组蛋白市场产生了重大影响。除此之外，重组蛋白表达技术的出现导致了广泛用于免疫治疗过程的高品质自身抗原的开发。此外，药物发现领域对重组蛋白精确测量生物标记的需求不断增长，也为全球市场创造了积极的前景。除此之外，用于生物製药的最新分子生物学方法的不断普及，以减少重组蛋白的蛋白水解或防止糖基化的部分或全部损失，预计将在预测期内提振全球重组蛋白市场。

本报告回答的关键问题

2023年全球重组蛋白市场规模有多大？
2024-2032年全球重组蛋白市场的预期成长率是多少？
推动全球重组蛋白市场的关键因素是什么？
COVID-19 对全球重组蛋白市场有何影响？
全球重组蛋白市场依应用划分如何？
基于最终用户的全球重组蛋白市场的细分如何？
全球重组蛋白市场的重点区域有哪些？
全球重组蛋白市场的主要参与者/公司有哪些？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 市场细分：按国家/地区
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Abcam plc
- Amgen Inc.
- Bio-RAD Laboratories Inc.
- Bio-Techne Corporation
- Bps Bioscience Inc.
- Enzo Biochem Inc.
- Genscript Biotech Corporation
- Merck KGaA
- Novo Nordisk A/S
- ProSpec-Tany TechnoGene Ltd
- Sanofi SA
- Thermo Fisher Scientific

简介目录图表

Product Code: SR112024A6079

The global recombinant protein market size reached US$ 1.90 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.58 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant protein market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Antibodies

Hormones

Growth Factors

Cytokines

Others

Breakup by Application:

Drug Discovery and Development

Academic Research

Biotechnology Research

Biopharmaceutical Production

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Biotechnology Companies

Academic and Research Institutes

Contract Research Organization

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

1. What was the size of the global recombinant protein market in 2023?
2. What is the expected growth rate of the global recombinant protein market during 2024-2032?
3. What are the key factors driving the global recombinant protein market?
4. What has been the impact of COVID-19 on the global recombinant protein market?
5. What is the breakup of the global recombinant protein market based on application?
6. What is the breakup of the global recombinant protein market based on the end user?
7. What are the key regions in the global recombinant protein market?
8. Who are the key players/companies in the global recombinant protein market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Recombinant Protein Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Antibodies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Hormones
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Growth Factors
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cytokines
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Drug Discovery and Development
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Academic Research
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Biotechnology Research
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Biopharmaceutical Production
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End User

8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Biotechnology Companies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Contract Research Organization
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abcam plc
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Amgen Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bio-RAD Laboratories Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Bio-Techne Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Bps Bioscience Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Enzo Biochem Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Genscript Biotech Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Merck KGaA
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Novo Nordisk A/S
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 ProSpec-Tany TechnoGene Ltd
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Sanofi S.A.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2023
Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2023
Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2023
Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: United States: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: China: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: India: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: France: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2023
Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Recombinant Protein Market: Competitive Structure
Table 7: Global: Recombinant Protein Market: Key Players

02-2729-4219

+886-2-2729-4219